These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6330349)

  • 21. Destruction of Trypanosoma cruzi by Natural killer cells.
    Hatcher FM; Kuhn RE
    Science; 1982 Oct; 218(4569):295-6. PubMed ID: 6812218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and Phenotypic Characterization of Inflammatory Cells from Clinical Samples: Purification of Macrophages from Trypanosoma cruzi-Infected Hearts.
    Eberhardt N; Sanmarco LM; Aoki MP
    Methods Mol Biol; 2019; 1955():381-395. PubMed ID: 30868542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi: correlations with parasite-specific antibody response.
    Tarleton RL; Kuhn RE
    Cell Immunol; 1983 Sep; 80(2):392-404. PubMed ID: 6411359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variations in cell-mediated immunity to Trypanosoma cruzi during experimental Chagas' disease.
    Maleckar JR; Kierszenbaum F
    Ann Trop Med Parasitol; 1983 Jun; 77(3):247-54. PubMed ID: 6226246
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of inflammatory cells in Chagas' disease. II. Interactions of mouse macrophages and human monocytes with intracellular forms of Trypanosoma cruzi: uptake and mechanism of destruction.
    Villalta F; Kierszenbaum F
    J Immunol; 1984 Dec; 133(6):3338-43. PubMed ID: 6436380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.
    Brener Z; Gazzinelli RT
    Int Arch Allergy Immunol; 1997 Oct; 114(2):103-10. PubMed ID: 9338602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Output of peritoneal cells into peritoneal dialysate. Cytochemical and functional studies.
    Cichocki T; Hanicki Z; Sułowicz W; Smoleński O; Kopeć J; Zembala M
    Nephron; 1983; 35(3):175-82. PubMed ID: 6633757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface antigens of the murine cytostatic peritoneal macrophage.
    Hogg N; Parish CR
    Immunology; 1980 Sep; 41(1):187-93. PubMed ID: 6933136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular Vesicles Shed By
    Lovo-Martins MI; Malvezi AD; Zanluqui NG; Lucchetti BFC; Tatakihara VLH; Mörking PA; de Oliveira AG; Goldenberg S; Wowk PF; Pinge-Filho P
    Front Immunol; 2018; 9():896. PubMed ID: 29755471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytophilic antibody in experimental Chagas' disease.
    Kuhn RE; Cassida GW
    J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of leukotriene C4 on macrophage association with and intracellular fate of Trypanosoma cruzi.
    Wirth JJ; Kierszenbaum F
    Mol Biochem Parasitol; 1985 Apr; 15(1):1-10. PubMed ID: 2859521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced mononuclear phagocytic activity during Trypanosoma cruzi infection in mice.
    Ortiz-Ortiz L; Ortega T; Capín R; Martínez T
    Int Arch Allergy Appl Immunol; 1976; 50(2):232-42. PubMed ID: 812831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosoma cruzi: T-cell-dependent mechanisms of resistance during chronic infection.
    Rottenberg ME; Cardoni RL; Sinagra A; Riarte A; Rodriguez Nantes I; Lauricella M; Segura EL
    Exp Parasitol; 1991 Aug; 73(2):127-36. PubMed ID: 1909649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypanosoma cruzi: flow cytometric analysis of lymphocyte subsets in susceptible and protected C3H/He mice.
    Powell MR; Rowland EC; Sidner RA
    Exp Parasitol; 1991 Aug; 73(2):197-202. PubMed ID: 1679718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.
    Kotner J; Tarleton R
    Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite.
    Giordanengo L; Guiñazú N; Stempin C; Fretes R; Cerbán F; Gea S
    Eur J Immunol; 2002 Apr; 32(4):1003-11. PubMed ID: 11920566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi.
    Kierszenbaum F; Knecht E; Budzko DB; Pizzimenti MC
    J Immunol; 1974 May; 112(5):1839-44. PubMed ID: 4361979
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased natural killer cell activity in experimental American trypanosomiasis.
    Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
    J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The induction of functional mononuclear and multinuclear macrophages in murine brugian filariasis: morphological and immunological properties.
    Mackenzie CD; Oxenham SL; Liron DA; Grennan D; Denham DA
    Trop Med Parasitol; 1985 Sep; 36(3):163-70. PubMed ID: 2934789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.